{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T14:50:41Z","timestamp":1791298241194,"version":"4.1.0"},"reference-count":75,"publisher":"Public Library of Science (PLoS)","issue":"7","license":[{"start":{"date-parts":[[2016,7,18]],"date-time":"2016-07-18T00:00:00Z","timestamp":1468800000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"South African Research Chairs Initiative of the Department of Science and Technology and National Research Foundation"},{"name":"Poliomyelitis Research Fund","award":["10\/44 PhD"],"award-info":[{"award-number":["10\/44 PhD"]}]},{"DOI":"10.13039\/100002322","name":"Schlumberger Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002322","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Oppenheimer Memorial Trus"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0159141","type":"journal-article","created":{"date-parts":[[2016,7,18]],"date-time":"2016-07-18T17:43:20Z","timestamp":1468863800000},"page":"e0159141","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":14,"title":["HIV-1 Subtype C Mosaic Gag Expressed by BCG and MVA Elicits Persistent Effector T Cell Responses in a Prime-Boost Regimen in Mice"],"prefix":"10.1371","volume":"11","author":[{"given":"Tsungai Ivai","family":"Jongwe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ros","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Douglass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shivan","family":"Chetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Chege","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Lise","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2016,7,18]]},"reference":[{"issue":"2","key":"ref1","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/00042560-200202010-00013","article-title":"WHO-UNAIDS Network for HIV Isolation and Characterization. Estimated global distribution and regional spread of HIV-1 genetic subtypes in the year 2000","volume":"29","author":"S Osmanov","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref2","unstructured":"UNAIDS. Global fact sheet July 2014. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.unaids.org\/sites\/default\/files\/en\/media\/unaids\/contentassets\/documents\/factsheet\/2014\/20140716_FactSheet_en.pdf\" xlink:type=\"simple\">http:\/\/www.unaids.org\/sites\/default\/files\/en\/media\/unaids\/contentassets\/documents\/factsheet\/2014\/20140716_FactSheet_en.pdf<\/ext-link>. Accessed November 2014."},{"key":"ref3","unstructured":"Department of Health. Republic of South Africa. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.health-e.org.za\/\" xlink:type=\"simple\">www.health-e.org.za\/<\/ext-link>. Accessed November 2014."},{"issue":"4","key":"ref4","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1089\/088922299311376","article-title":"A predominantly HIV type 1 subtype C-restricted epidemic in South African urban populations","volume":"15","author":"JH Van Harmelen","year":"1999","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"5","key":"ref5","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/00126334-200012150-00002","article-title":"Prenatal transmission of subtype C HIV-1 in Zimbabwe: HIV-1 RNA and DNA in maternal and cord blood","volume":"25","author":"H Guevara","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"3","key":"ref6","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1089\/aid.2006.0232","article-title":"HIV type 1 subtype C <italic>gag<\/italic> and <italic>nef<\/italic> diversity in Southern Africa","volume":"23","author":"H Bredell","year":"2007","journal-title":"AIDS Res Hum Retroviruses"},{"issue":"1","key":"ref7","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1128\/JVI.73.1.152-160.1999","article-title":"Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination","volume":"73","author":"KS Lole","year":"1999","journal-title":"J Virol"},{"issue":"5","key":"ref8","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1097\/00126334-200408150-00013","article-title":"Surveillance of HIV-1 subtypes among heterosexuals in England and Wales, 1997\u20132000","volume":"36","author":"ID Tatt","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"1","key":"ref9","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.virol.2012.08.048","article-title":"The increasing prevalence of HIV-1 subtype C in Southern Brazil and its dispersion through the continent","volume":"435","author":"T Gr\u00e4f","year":"2013","journal-title":"Virology"},{"key":"ref10","doi-asserted-by":"crossref","DOI":"10.1186\/1743-422X-9-156","article-title":"Clinical, epidemiological and molecular features of the HIV-1 subtype C and recombinant forms that are circulating in the city of Sao Paulo, Brazil","volume":"9","author":"R Alcalde","year":"2012","journal-title":"Virol J"},{"key":"ref11","article-title":"Prospects for a globally effective HIV-1 vaccine","author":"JL Excler","year":"2015","journal-title":"Vaccine"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.coi.2015.05.007","article-title":"New approaches to HIV vaccine development","volume":"35","author":"BF Haynes","year":"2015","journal-title":"Curr Opin Immunol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"124","DOI":"10.3389\/fimmu.2015.00124","article-title":"A New Scientific Paradigm may be Needed to Finally Develop an HIV Vaccine","volume":"6","author":"J Esparza","year":"2015","journal-title":"Front Immunol"},{"issue":"1","key":"ref14","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nm1520","article-title":"CD8+ T-cell responses to different HIV proteins have discordant associations with viral load","volume":"13","author":"P Kiepiela","year":"2007","journal-title":"Nat Med"},{"issue":"10","key":"ref15","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1097\/QAD.0b013e3283478575","article-title":"Gag-specific CD4+ T-cell responses are associated with virological control of paediatric HIV-1 infection","volume":"25","author":"A Prendergast","year":"2011","journal-title":"AIDS"},{"issue":"1","key":"ref16","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1128\/JVI.05577-11","article-title":"HIV-specific CD4 T cell responses to different viral proteins have discordant associations with viral load and clinical outcome","volume":"86","author":"S Ranasinghe","year":"2012","journal-title":"J Virol"},{"issue":"10","key":"ref17","doi-asserted-by":"crossref","first-page":"3968","DOI":"10.3390\/v6103968","article-title":"Challenges in the design of a T cell vaccine in the context of HIV-1 diversity","volume":"6","author":"M Tongo","year":"2014","journal-title":"Viruses"},{"key":"ref18","article-title":"HIV-1 vaccine immunogen design strategies","volume":"12","author":"JK Mann","year":"2015","journal-title":"Virol J"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nm1461","article-title":"Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants","volume":"13","author":"W Fischer","year":"2007","journal-title":"Nat Med"},{"issue":"17","key":"ref20","doi-asserted-by":"crossref","first-page":"8300","DOI":"10.1128\/JVI.00114-09","article-title":"T-cell vaccine strategies for human immunodeficiency virus, the virus with a thousand faces","volume":"83","author":"BT Korber","year":"2009","journal-title":"J Virol"},{"issue":"2","key":"ref21","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.virol.2012.03.012","article-title":"Breadth of cellular and humoral immune responses elicited in rhesus monkeys by multi-valent mosaic and consensus immunogens","volume":"428","author":"S Santra","year":"2012","journal-title":"Virology"},{"issue":"10","key":"ref22","doi-asserted-by":"crossref","first-page":"e44769","DOI":"10.1371\/journal.pone.0044769","article-title":"Designing and testing broadly-protective filoviral vaccines optimized for cytotoxic T-lymphocyte epitope coverage","volume":"7","author":"PW Fenimore","year":"2012","journal-title":"PLoS One"},{"issue":"7","key":"ref23","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1038\/mt.2013.61","article-title":"Induction of broad cytotoxic T cells by protective DNA vaccination against Marburg and Ebola","volume":"21","author":"DJ Shedlock","year":"2013","journal-title":"Mol Ther"},{"issue":"8","key":"ref24","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1084\/jem.185.8.1423","article-title":"Patterns of immunodominance in HIV-1-specific cytotoxic T lymphocyte responses in two human histocompatibility leukocyte antigens (HLA)-identical siblings with HLA-A*0201 are influenced by epitope mutation","volume":"185","author":"PJ Goulder","year":"1997","journal-title":"J Exp Med"},{"issue":"17","key":"ref25","doi-asserted-by":"crossref","first-page":"9538","DOI":"10.1128\/JVI.01739-14","article-title":"Characterization and immunogenicity of a novel mosaic M HIV-1 gp140 trimer","volume":"88","author":"JP Nkolola","year":"2014","journal-title":"J Virol"},{"issue":"12","key":"ref26","doi-asserted-by":"crossref","first-page":"6462","DOI":"10.1128\/JVI.00383-15","article-title":"Comparison of Immunogenicity in Rhesus Macaques of Transmitted-Founder, HIV-1 Group M Consensus, and Trivalent Mosaic Envelope Vaccines Formulated as a DNA Prime, NYVAC, and Envelope Protein Boost","volume":"89","author":"SL Hulot","year":"2015","journal-title":"J Virol"},{"issue":"9","key":"ref27","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1136\/adc.2011.214494","article-title":"Prospects for elimination of childhood tuberculosis: the role of new vaccines","volume":"96","author":"M Hatherill","year":"2011","journal-title":"Arch Dis Child"},{"issue":"1579","key":"ref28","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1098\/rstb.2011.0097","article-title":"Tuberculosis vaccines: beyond bacille Calmette-Guerin","volume":"366","author":"H McShane","year":"2011","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"issue":"5","key":"ref29","doi-asserted-by":"crossref","first-page":"e1002607","DOI":"10.1371\/journal.ppat.1002607","article-title":"Vaccines against tuberculosis: where are we and where do we need to go?","volume":"8","author":"TH Ottenhoff","year":"2012","journal-title":"PLoS Pathog"},{"key":"ref30","first-page":"574591","article-title":"<italic>Mycobacterium bovis<\/italic> Bacille Calmette-Guerin as a Vaccine Vector for Global Infectious Disease Control","volume":"2011","author":"K Matsuo","year":"2011","journal-title":"Tuberc Res Treat"},{"issue":"9","key":"ref31","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1586\/14760584.2015.1068124","article-title":"Applications of bacillus Calmette-Guerin and recombinant bacillus Calmette-Guerin in vaccine development and tumor immunotherapy","volume":"14","author":"YQ Zheng","year":"2015","journal-title":"Expert Rev Vaccines"},{"issue":"9","key":"ref32","doi-asserted-by":"crossref","first-page":"5151","DOI":"10.1128\/JVI.03178-12","article-title":"Robust immunity to an auxotrophic <italic>Mycobacterium bovis<\/italic> BCG-VLP prime-boost HIV vaccine candidate in a nonhuman primate model","volume":"87","author":"GK Chege","year":"2013","journal-title":"J Virol"},{"issue":"5","key":"ref33","doi-asserted-by":"crossref","first-page":"3031","DOI":"10.1128\/IAI.72.5.3031-3037.2004","article-title":"Protection elicited by a double leucine and pantothenate auxotroph of <italic>Mycobacterium tuberculosis<\/italic> in guinea pigs","volume":"72","author":"SL Sampson","year":"2004","journal-title":"Infect Immun"},{"issue":"17","key":"ref34","doi-asserted-by":"crossref","first-page":"9408","DOI":"10.1128\/JVI.00707-07","article-title":"Vaccine platform for prevention of tuberculosis and mother-to-child transmission of human immunodeficiency virus type 1 through breastfeeding","volume":"81","author":"EJ Im","year":"2007","journal-title":"J Virol"},{"issue":"3","key":"ref35","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1128\/IAI.63.3.1004-1012.1995","article-title":"In vivo growth characteristics of leucine and methionine auxotrophic mutants of <italic>Mycobacterium bovis<\/italic> BCG generated by transposon mutagenesis","volume":"63","author":"RA McAdam","year":"1995","journal-title":"Infect Immun"},{"issue":"6","key":"ref36","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.tube.2007.07.006","article-title":"Auxotrophic complementation as a selectable marker for stable expression of foreign antigens in <italic>Mycobacterium bovis<\/italic> BCG","volume":"87","author":"S Borsuk","year":"2007","journal-title":"Tuberculosis (Edinb)"},{"issue":"3","key":"ref37","doi-asserted-by":"crossref","first-page":"e32769","DOI":"10.1371\/journal.pone.0032769","article-title":"Priming with a recombinant pantothenate auxotroph of <italic>Mycobacterium bovis<\/italic> BCG and boosting with MVA elicits HIV-1 Gag specific CD8+ T cells","volume":"7","author":"R Chapman","year":"2012","journal-title":"PLoS One"},{"issue":"10","key":"ref38","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1038\/nm765","article-title":"A pantothenate auxotroph of <italic>Mycobacterium tuberculosis<\/italic> is highly attenuated and protects mice against tuberculosis","volume":"8","author":"VK Sambandamurthy","year":"2002","journal-title":"Nat Med"},{"issue":"2","key":"ref39","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1006\/viro.1998.9123","article-title":"The complete genomic sequence of the modified vaccinia Ankara strain: comparison with other orthopoxviruses","volume":"244","author":"G Antoine","year":"1998","journal-title":"Virology"},{"issue":"39","key":"ref40","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1016\/j.vaccine.2013.03.017","article-title":"Modified Vaccinia virus Ankara: innate immune activation and induction of cellular signalling","volume":"31","author":"PJ Price","year":"2013","journal-title":"Vaccine"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"Mercer AA, Schmidt A, Weber O editors. Poxviruses.; 2007.","DOI":"10.1007\/978-3-7643-7557-7"},{"issue":"2","key":"ref42","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1006\/viro.1997.8845","article-title":"Host range and cytopathogenicity of the highly attenuated MVA strain of vaccinia virus: propagation and generation of recombinant viruses in a nonhuman mammalian cell line","volume":"238","author":"MW Carroll","year":"1997","journal-title":"Virology"},{"issue":"1","key":"ref43","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/0092-1157(88)90025-X","article-title":"The stability and immunogenicity of a dispersed-grown freeze-dried Pasteur BCG vaccine","volume":"16","author":"M Gheorghiu","year":"1988","journal-title":"J Biol Stand"},{"key":"ref44","author":"T Parish","year":"2001"},{"issue":"2","key":"ref45","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1089\/aid.2007.0205","article-title":"Construction, characterization, and immunogenicity of a multigene modified vaccinia Ankara (MVA) vaccine based on HIV type 1 subtype C","volume":"24","author":"WA Burgers","year":"2008","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref46","unstructured":"Y. J. Shen. An investigation into the use of lumpy skin disease virus as a vaccine vector for a potential HIV-1 vaccineUniversity of Cape Town; 2010."},{"issue":"2","key":"ref47","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1099\/vir.0.81379-0","article-title":"Design and preclinical evaluation of a multigene human immunodeficiency virus type 1 subtype C DNA vaccine for clinical trial","volume":"87","author":"WA Burgers","year":"2006","journal-title":"Journal of General Virology"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.cacc.2006.03.005","article-title":"Multiple comparisons","volume":"17","author":"MO Columb","year":"2006","journal-title":"Current Anaesthesia & Critical Care"},{"issue":"4","key":"ref49","doi-asserted-by":"crossref","first-page":"282","DOI":"10.2174\/157016210791208686","article-title":"Recombinant <italic>Mycobacterium bovis<\/italic> BCG as an HIV vaccine vector","volume":"8","author":"R Chapman","year":"2010","journal-title":"Curr HIV Res"},{"issue":"3","key":"ref50","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/nm.2108","article-title":"Mosaic vaccines elicit CD8+ T lymphocyte responses that confer enhanced immune coverage of diverse HIV strains in monkeys","volume":"16","author":"S Santra","year":"2010","journal-title":"Nat Med"},{"issue":"3","key":"ref51","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nm.2089","article-title":"Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys","volume":"16","author":"DH Barouch","year":"2010","journal-title":"Nat Med"},{"issue":"5","key":"ref52","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1128\/JVI.02256-08","article-title":"Expanded breadth of the T-cell response to mosaic human immunodeficiency virus type 1 envelope DNA vaccination","volume":"83","author":"WP Kong","year":"2009","journal-title":"J Virol"},{"key":"ref53","unstructured":"Murphy K, P. editor. Janeway&apos;s Immunobiology.; 2011."},{"issue":"14","key":"ref54","doi-asserted-by":"crossref","first-page":"7176","DOI":"10.1128\/JVI.00687-09","article-title":"Elucidating and minimizing the loss by recombinant vaccinia virus of human immunodeficiency virus gene expression resulting from spontaneous mutations and positive selection","volume":"83","author":"LS Wyatt","year":"2009","journal-title":"J Virol"},{"issue":"1","key":"ref55","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.jviromet.2010.11.003","article-title":"Engineering recombinant poxviruses using a compact GFP-blasticidin resistance fusion gene for selection","volume":"171","author":"YC Wong","year":"2011","journal-title":"J Virol Methods"},{"issue":"3","key":"ref56","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nm.1935","article-title":"Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge","volume":"15","author":"SG Hansen","year":"2009","journal-title":"Nat Med"},{"issue":"7348","key":"ref57","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1038\/nature10003","article-title":"Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine","volume":"473","author":"SG Hansen","year":"2011","journal-title":"Nature"},{"issue":"7469","key":"ref58","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1038\/nature12519","article-title":"Immune clearance of highly pathogenic SIV infection","volume":"502","author":"SG Hansen","year":"2013","journal-title":"Nature"},{"issue":"8","key":"ref59","doi-asserted-by":"crossref","first-page":"e42559","DOI":"10.1371\/journal.pone.0042559","article-title":"Pre-clinical development of BCG.HIVA(CAT), an antibiotic-free selection strain, for HIV-TB pediatric vaccine vectored by lysine auxotroph of BCG","volume":"7","author":"N Saubi","year":"2012","journal-title":"PLoS One"},{"issue":"8","key":"ref60","doi-asserted-by":"crossref","first-page":"e71601","DOI":"10.1371\/journal.pone.0071601","article-title":"Priming with recombinant auxotrophic BCG expressing HIV-1 Gag, RT and Gp120 and boosting with recombinant MVA induces a robust T cell response in mice","volume":"8","author":"R Chapman","year":"2013","journal-title":"PLoS One"},{"issue":"7","key":"ref61","doi-asserted-by":"crossref","first-page":"e103314","DOI":"10.1371\/journal.pone.0103314","article-title":"The use of directed evolution to create a stable and immunogenic recombinant BCG expressing a modified HIV-1 Gag antigen","volume":"9","author":"R Chapman","year":"2014","journal-title":"PLoS One"},{"issue":"6","key":"ref62","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.4049\/jimmunol.172.6.3491","article-title":"Prolonged antigen presentation, APC-, and CD8+ T cell turnover during mycobacterial infection: comparison with Listeria monocytogenes","volume":"172","author":"H van Faassen","year":"2004","journal-title":"J Immunol"},{"issue":"9","key":"ref63","doi-asserted-by":"crossref","first-page":"5341","DOI":"10.4049\/jimmunol.174.9.5341","article-title":"Reducing the stimulation of CD8+ T cells during infection with intracellular bacteria promotes differentiation primarily into a central (CD62LhighCD44high) subset","volume":"174","author":"H van Faassen","year":"2005","journal-title":"J Immunol"},{"key":"ref64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0065-2776(00)75001-2","article-title":"Exploiting the immune system: toward new vaccines against intracellular bacteria","volume":"75","author":"J Hess","year":"2000","journal-title":"Adv Immunol"},{"issue":"6","key":"ref65","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1054\/tube.2002.0374","article-title":"Expression of foreign genes in Mycobacterium bovis BCG strains using different promoters reveals instability of the hsp60 promoter for expression of foreign genes in <italic>Mycobacterium bovis<\/italic> BCG strains","volume":"82","author":"M Al-Zarouni","year":"2002","journal-title":"Tuberculosis (Edinb)"},{"issue":"2","key":"ref66","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1128\/JVI.02030-10","article-title":"HIV-1-specific interleukin-21+ CD4+ T cell responses contribute to durable viral control through the modulation of HIV-specific CD8+ T cell function","volume":"85","author":"MF Chevalier","year":"2011","journal-title":"J Virol"},{"issue":"1","key":"ref67","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1002\/eji.200324231","article-title":"CD4 T cells guarantee optimal competitive fitness of CD8 memory T cells","volume":"34","author":"P Johansen","year":"2004","journal-title":"Eur J Immunol"},{"issue":"2","key":"ref68","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.4049\/jimmunol.179.2.1113","article-title":"The antiviral CD8+ T cell response is differentially dependent on CD4+ T cell help over the course of persistent infection","volume":"179","author":"CC Kemball","year":"2007","journal-title":"J Immunol"},{"issue":"10","key":"ref69","doi-asserted-by":"crossref","first-page":"6350","DOI":"10.4049\/jimmunol.178.10.6350","article-title":"Requirement for CD4 T cell help in maintenance of memory CD8 T cell responses is epitope dependent","volume":"178","author":"EA Ramsburg","year":"2007","journal-title":"J Immunol"},{"issue":"3","key":"ref70","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/nm1380","article-title":"Pathogenesis of HIV infection: what the virus spares is as important as what it destroys","volume":"12","author":"Z Grossman","year":"2006","journal-title":"Nat Med"},{"issue":"18","key":"ref71","doi-asserted-by":"crossref","first-page":"9842","DOI":"10.1128\/JVI.78.18.9842-9853.2004","article-title":"A consecutive priming-boosting vaccination of mice with simian immunodeficiency virus (SIV) gag\/pol DNA and recombinant vaccinia virus strain DIs elicits effective anti-SIV immunity","volume":"78","author":"K Someya","year":"2004","journal-title":"J Virol"},{"issue":"12","key":"ref72","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1073\/pnas.0408773102","article-title":"Characterization of functional and phenotypic changes in anti-Gag vaccine-induced T cell responses and their role in protection after HIV-1 infection","volume":"102","author":"MR Betts","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"12","key":"ref73","doi-asserted-by":"crossref","first-page":"4781","DOI":"10.1182\/blood-2005-12-4818","article-title":"HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T cells","volume":"107","author":"MR Betts","year":"2006","journal-title":"Blood"},{"issue":"20","key":"ref74","doi-asserted-by":"crossref","first-page":"7239","DOI":"10.1073\/pnas.0502393102","article-title":"HIV-1-specific IFN-gamma\/IL-2-secreting CD8 T cells support CD4-independent proliferation of HIV-1-specific CD8 T cells","volume":"102","author":"SC Zimmerli","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"ref75","doi-asserted-by":"crossref","first-page":"e1000917","DOI":"10.1371\/journal.ppat.1000917","article-title":"Perforin expression directly ex vivo by HIV-specific CD8 T-cells is a correlate of HIV elite control","volume":"6","author":"AR Hersperger","year":"2010","journal-title":"PLoS Pathog"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0159141","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T03:11:19Z","timestamp":1600917079000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0159141"}},"subtitle":[],"editor":[{"given":"Roger","family":"Le Grand","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2016,7,18]]},"references-count":75,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2016,7,18]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0159141","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,7,18]]}}}